1.Research advance on the pathogenesis of autosomal recessive spastic ataxia of Charlevoix-Saguenay.
Rong FU ; Man DING ; Zuneng LU
Chinese Journal of Medical Genetics 2023;40(1):121-124
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a rare and early-onset neurodegenerative disease caused by variants of the SACS gene which maps to chromosome 13q11 and encodes sacsin protein. Sacsin is highly expressed in large motor neurons, in particular cerebellar Purkinje cells. This article has provided a review for the structure and function of sacsin protein and the mechanisms underlying abnormalities of sacsin in ARSACS disease.
Humans
;
Spinocerebellar Ataxias/pathology*
;
Ataxia/genetics*
;
Muscle Spasticity/genetics*
2.Clinical and genetics characteristics of adult-onset cerebrotendinous xanthomatosis: analysis of a Chinese pedigree.
Bo ZHAO ; Zhi Wei WANG ; Yi Mo ZHANG ; Ying Xin YU ; Sheng YAO ; Jin Jing ZHAO ; Hang LI ; Li LIANG ; Shu Yi PAN ; Hai Rong QIAN
Chinese Journal of Internal Medicine 2023;62(4):401-409
Objective: Clinical manifestations, imaging findings, pathologic features, and genetic mutations of Chinese adult patients with cerebrotendinous xanthomatosis (CTX) were analyzed in order to achieve a greater understanding of CTX that can improve early detection, diagnosis, and treatment. Methods: Clinical data including medical history, neurologic and auxiliary examinations, imaging findings, and genetic profile were collected for an adult patient with CTX admitted to the Sixth Medical Center of Chinese People's Liberation Army General Hospital in August 2020. Additionally, a systematic review of genetically diagnosed Chinese adult CTX cases reported in major databases in China and other countries was performed and age of onset, first symptoms, common signs and symptoms, pathologic findings, imaging changes, and gene mutations were analyzed. Results: The proband was a 39-year-old female with extensive, early-onset nervous system manifestations including cognitive dysfunction and ataxia. Systemic lesions included juvenile cataract and a tendon mass. Cranial magnetic resonance imaging revealed cerebral atrophy, symmetric white matter changes predominantly in the pyramidal tract, and lesions in the cerebellar dentate nucleus. A novel homozygous mutation in the sterol-27-hydroxylase (CYP27A1) gene (c.1477-2A>C) was identified. There were no family members with similar clinical presentation although some were carriers of the c.1477-2A>C mutation. The patient showed a good response to deoxycholic acid treatment. Totally there were 56 cases of adult CTX patients in China, mostly in East China (31/56, 55.4%), at a male-to-female ratio of 1.8 to 1. Multiple organs and tissues including nervous system, tendon, lens, lung, and skeletal muscle were affected in these cases. The most common neurologic manifestations were cognitive dysfunction (44/52, 84.6%) and ataxia (44/51, 86.3%). The cases were characterized by early onset, chronic progressive damage of multiple systems, long disease course, and delayed diagnosis, making the disease difficult to manage clinically and resulting in poor prognosis. The 2 most common genetic mutations in Chinese adult CTX patients were c.1263+1G>A and c.379C>T. Exon 2 of the CYP27A1 gene was identified as a mutation hot spot. Conclusions: Chinese adult patients with CTX have complex clinical characteristics, a long diagnostic cycle, and various CYP27A1 gene mutations. Early diagnosis and intervention can improve the prognosis of these patients.
Humans
;
Male
;
Adult
;
Female
;
Xanthomatosis, Cerebrotendinous/pathology*
;
Pedigree
;
Cholestanetriol 26-Monooxygenase/genetics*
;
Mutation
;
Ataxia
3.Spinocerebellar Ataxia Type 6 in Two Korean Families.
Seong Ho KOH ; Hak Jae NOH ; Seung Hyun KIM ; Hee Tae KIM ; Dong Jin SHIN ; Myung Kwon KIM ; Sung Sup PARK ; Ji Yeon KIM ; Beom S JEON
Journal of the Korean Neurological Association 2000;18(3):298-303
BACKGROUND: Spinocerebellar ataxia 6 (SCA6) is an autosomal dominant spinocerebellar degeneration and caused by the expansion of the polymorphic CAG repeat in the human alpha 1A voltage-dependent calcium channel subunit gene. In this study, we report the clinical and molecular genetic characteristics of SCA6 in 2 Korean families. We further describe that SCA6 and Episodic ataxia type 2 are simultaneously developed in same family showing no intergenerational changes of CAG repeat numbers. METHODS: Seventeen members of one family and nine of the other received detailed neurological examination and history taking at least one occasion. After the screening test, molecular diagnostic test by using Zhuchenko's method were performed in 13 patients in one family and 3 in the other, respectively. RESULTS: Normal range of CAG repeat in 92 normal individuals was 8 to 17. In this study, the numbers of CAG repeat in one family was 26 and in another was 23. There were no intergenerational differences in the numbers of CAG repeat. Despite the same number of CAG repeat, the clinical anticipation were found. Only one showed episodic ataxia clinically. CONCLUSIONS: Comparing with other types of SCA, the SCA6 had several remarkable characteristics: 1) very small CAG expansions (21-27 repeats) lead to clinical symptoms and the repeat numbers are relatively stable, 2) clinical anticipation is observed despite the relatively stable repeat on intergenerational transmission. The finidngs that an EA2 and a SCA6 exist in a same family may be suggest that two disease are the same disorder with a high phenotypic variablity.
Ataxia
;
Calcium Channels
;
Humans
;
Mass Screening
;
Molecular Biology
;
Neurologic Examination
;
Pathology, Molecular
;
Reference Values
;
Spinocerebellar Ataxias*
;
Spinocerebellar Degenerations
4.Fragile X-associated tremor/ataxia syndrome.
Wei-wei HAN ; Lin ZHANG ; Hong JIANG ; Bei-sha TANG
Chinese Journal of Medical Genetics 2011;28(1):52-55
Fragile X-associated tremor/ataxia syndrome(FXTAS) is a neurodegenerative disease caused by FMR1 gene permutation(PM). The main clinical manifestations are intention tremor and/or ataxia, and the pathogenesis was related to RNA toxicity. In this paper, the research progress of clinical manifestatios, pathological characteristics, epidemiology and molecular mechanisms will be reviewed.
Ataxia
;
genetics
;
Female
;
Fragile X Mental Retardation Protein
;
genetics
;
Fragile X Syndrome
;
complications
;
diagnosis
;
genetics
;
pathology
;
Humans
;
Male
;
Tremor
;
genetics
5.Urethral Pressure Measurement as a Tool for the Urodynamic Diagnosis of Detrusor Sphincter Dyssynergia.
Lauren E CORONA ; Anne P CAMERON ; J Quentin CLEMENS ; Yongmei QIN ; John T STOFFEL
International Neurourology Journal 2018;22(4):268-274
PURPOSE: To describe a technique for urodynamic diagnosis of detrusor sphincter dyssynergia (DSD) using urethral pressure measurements and examine potential associations between urethral pressure and bladder physiology among patients with DSD. METHODS: Multiple sclerosis (MS) and spinal cord injured (SCI) patients with known DSD diagnosed on videourodynamics (via electromyography or voiding cystourethrography) were retrospectively identified. Data from SCI and MS patients with detrusor overactivity (DO) without DSD were abstracted as control group. Urodynamics tracings were reviewed and urethral pressure DSD was defined based on comparison of DSD and control groups. RESULTS: Seventy-two patients with DSD were identified. Sixty-two (86%) had >20 cm H₂O urethral pressure amplitude during detrusor contraction. By comparison, 5 of 23 (22%) of control group had amplitude of >20 cm H₂O during episode of DO. Mean duration of urethral pressure DSD episode was 66 seconds (range, 10–500 seconds) and mean urethral pressure amplitude was 73 cm H₂O (range, 1–256 cm H₂O). Longer (>30 seconds) DSD episodes were significantly associated with male sex (81% vs. 50%, P=0.013) and higher bladder capacity (389 mL vs. 219 mL, P=0.0004). Urethral pressure amplitude measurements during DSD were not associated with significant urodynamic variables or neurologic pathology. CONCLUSIONS: Urethral pressure amplitude of >20 cm H2O during detrusor contraction occurred in 86% of patients with known DSD. Longer DSD episodes were associated with larger bladder capacity. Further studies exploring the relationship between urethral pressure measurements and bladder physiology could phenotype DSD as a measurable variable rather than a categorical observation.
Ataxia*
;
Diagnosis*
;
Electromyography
;
Humans
;
Male
;
Multiple Sclerosis
;
Pathology
;
Phenotype
;
Physiology
;
Retrospective Studies
;
Spinal Cord
;
Spinal Cord Injuries
;
Urinary Bladder
;
Urodynamics*
6.Glutamate and GABA concentrations in the cerebellum of novel ataxic mutant Pogo mice.
Ki Hyung KIM ; Jeoung Hee HA ; Seung Hyuk CHUNG ; Chul Tae KIM ; Sun Kyung KIM ; Byung Hwa HYUN ; Kazuhiko SAWADA ; Yoshihiro FUKUI ; Il Kwon PARK ; Geun jwa LEE ; Bum Kyeong KIM ; Nam Seob LEE ; Young Gil JEONG
Journal of Veterinary Science 2003;4(3):209-212
The Pogo mouse is an autosomal recessive ataxic mutant that arose spontaneously in the inbred KJR/MsKist strain derived originally from Korean wild mice. The ataxic phenotype is characterized by difficulty in maintaining posture and side to side stability, faulty coordination between limbs and trunk, and the consequent inability to walk straight. In the present study, the cerebellar concentrations of glutamate and GABA were analyzed, since glutamate is a most prevalent excitatory neurotransmitter whereas gammar-aminobutyric acid (GABA) is one of the most abundant inhibitory neurotransmitters, which may be the main neurotransmitters related with the ataxia and epilepsy. The concentration of glutamate of cerebellum decreased significantly in ataxic mutant Pogo mouse compared to those of control mouse. However, GABA concentration was not decrease. These results suggested that the decrease in glutamate concentration may contribute to ataxia in mutant Pogo mouse.
Animals
;
Calcium-Binding Protein, Vitamin D-Dependent/metabolism
;
Cerebellum/*metabolism/pathology
;
Gait Ataxia/*metabolism/pathology
;
Glutamic Acid/*metabolism
;
Immunohistochemistry
;
Mice
;
Mice, Mutant Strains
;
gamma-Aminobutyric Acid/*metabolism
7.Pontine Necrosis Related with Radiation Therapy, Complicated with Spontaneous Hemorrhage.
Ha Min KIM ; Bo Young HONG ; Jong In LEE ; Joon Sung KIM ; Seong Hoon LIM
Brain & Neurorehabilitation 2017;10(1):e1-
The brain necrosis induced by radiation therapy (RT) is an uncommon pathology of brain. A case of spontaneous hemorrhage at necrotic brain is also rare. A 52-year-old man who had nasopharyngeal carcinoma and had been treated with RT, presented with gait disturbance, dizziness, ataxia, dysarthria, and dysphagia. Magnetic resonance imaging (MRI) demonstrated progressed radiation necrosis of pons, and spontaneous hemorrhage at the site of necrosis. The hematoma was diminished by conservative treatment. However, the patient’s neurologic symptoms did not recover. Two years later, spontaneous bleeding recurred at necrotic brain. His neurologic symptoms worsened. One year later, his neurologic symptoms were more progressed. He showed severe dysphagia, profound weakness and respiratory failure. This case provides the description of relapsed spontaneous hemorrhage and medullary dysfunction caused by pontine necrosis and progressed post-radiation injury, complicated with hemorrhage, and urges caution in that the necrotic brain tissue may be vulnerable to bleeding.
Ataxia
;
Brain
;
Deglutition Disorders
;
Dizziness
;
Dysarthria
;
Gait
;
Hematoma
;
Hemorrhage*
;
Humans
;
Magnetic Resonance Imaging
;
Middle Aged
;
Necrosis*
;
Neurologic Manifestations
;
Pathology
;
Pons
;
Respiratory Insufficiency
8.MiR-181a Promotes Proliferation of Human Acute Myeloid Leukemia Cells by Targeting ATM.
Jia-Ye HUA ; Ying FENG ; Ying PANG ; Xu-Hong ZHOU ; Bing XU ; Mu-Xia YAN
Journal of Experimental Hematology 2016;24(2):347-351
OBJECTIVETo investigate miR-181a function and regulation mechanism by identifying miR-181a target genes in acute myeloid leukemia (AML).
METHODSThe HL-60 cells of human AML was transfected by small molecular analog miR-181a, the cell proliferation was detected by CCK-8 method after electroporation in HL-60 cell lines. Target genes of miR-181a were predicted and analyzed by the bioinformatics software and database. Target genes were confirmed by HL-60 cell line and the patient leukemia cells.
RESULTSOverexpressed miR-181a in HL-60 cell line significantly enhanced cell proliferation compared with that in control (P < 0.05). Dual luciferase reporter gene assay showed that miR-181a significantly suppressed the reporter gene activity containing ATM 3'-UTR by about 56.8% (P < 0.05), but it didn't suppress the reporter gene activity containing 3'-UTR ATM mutation. Western blot showed that miR-181a significantly downregulated the expression of ATM in human leukemia cells. It is also found that miR-181a was significantly increased in AML, which showed a negative correlation with ATM expression.
CONCLUSIONmiR-181a promotes cell proliferation in AML by regulating the tumor suppressor ATM, thus it plays the role as oncogene in pathogenesis of AML.
Ataxia Telangiectasia Mutated Proteins ; metabolism ; Cell Proliferation ; Down-Regulation ; HL-60 Cells ; Humans ; Leukemia, Myeloid, Acute ; metabolism ; pathology ; MicroRNAs ; genetics ; metabolism ; Transfection
9.Assessing a Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease) with 7T MR Imaging.
Christoph MOENNINGHOFF ; Oliver KRAFF ; Marc SCHLAMANN ; Mark E LADD ; Zaza KATSARAVA ; Elke R GIZEWSKI
Korean Journal of Radiology 2010;11(2):244-248
Lhermitte-Duclos disease (LDD; dysplastic cerebellar gangliocytoma) is a rare hamartomatous lesion of the cerebellar cortex and this was first described in 1920. LDD is considered to be part of the autosomal-dominant phacomatosis and cancer syndrome Cowden disease (CS). We examined the brain of a 46-year-old man, who displayed the manifestations of CS, with 7 Tesla (T) and 1.5T MRI and 1.5T MR spectroscopy (1H-MRS). We discuss the possible benefits of employing ultrahigh-field MRI for making the diagnosis of this rare lesion.
Cerebellar Cortex/pathology
;
Cerebellar Neoplasms/complications/*pathology
;
Diagnosis, Differential
;
Gait Ataxia/etiology
;
Hamartoma Syndrome, Multiple/complications/*pathology
;
Humans
;
Image Processing, Computer-Assisted/methods
;
Magnetic Resonance Imaging/*methods
;
Magnetic Resonance Spectroscopy/methods
;
Magnetics
;
Male
;
Middle Aged
;
Vertigo/etiology
10.Dura Mater Graft-Associated Creutzfeldt-Jakob Disease: The First Case in Korea.
Hye Lim KIM ; Ju Young DO ; Han Jeong CHO ; Yong Chul JEON ; Seok Joo PARK ; Hyeo Il MA ; Jun Ho SONG ; Yul LEE ; Hyun CHOI ; Kyung Chan CHOI ; Yong Sun KIM ; Inga ZERR ; Kai KALLENBERG ; Yun Joong KIM
Journal of Korean Medical Science 2011;26(11):1515-1517
Since 1987, dura mater graft-associated iatrogenic Creutzfeldt-Jakob disease (dCJD) has been reported in many countries. We report the first case of dCJD in Korea. A 54-yr-old woman, who underwent resection of the meningioma in the left frontal region and received a dura mater graft 23 yr ago presented with dysesthesia followed by psychiatric symptoms and ataxia. Her neurological symptoms rapidly progressed to such an extent that she exhibited myoclonus, dementia, and pyramidal and extrapyramidal signs within 8 weeks. The 14-3-3 protein was detected in her cerebrospinal fluid; however, an electroencephalogram did not reveal characteristic positive sharp wave complexes. Diffusion-weighted magnetic resonance images, obtained serially over 64 days, revealed the rapid progression of areas of high signal intensity in the caudate nucleus and cingulate gyrus to widespread areas of high signal intensity in the cortex and basal ganglia. Pathological examination of brain biopsy specimens confirmed the presence of spongiform changes and deposition of prion protein in the neurons and neuropils.
14-3-3 Proteins/cerebrospinal fluid
;
Ataxia/diagnosis
;
Brain/pathology
;
Creutzfeldt-Jakob Syndrome/diagnosis/pathology/*transmission
;
Dementia/diagnosis
;
Dura Mater/*transplantation
;
Female
;
Humans
;
Meningioma/surgery
;
Middle Aged
;
Paresthesia/diagnosis
;
Prions/*analysis
;
Republic of Korea
;
Transplants